Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) Consolidated Net Income (2020 - 2025)

Beauty Health (SKIN) has disclosed Consolidated Net Income for 6 consecutive years, with -$8.1 million as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income rose 21.55% to -$8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.5 million through Dec 2025, up 67.26% year-over-year, with the annual reading at -$9.5 million for FY2025, 67.29% up from the prior year.
  • Consolidated Net Income for Q4 2025 was -$8.1 million at Beauty Health, up from -$11.0 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $31.5 million in Q1 2022, with the low at -$215.2 million in Q3 2021.
  • Average Consolidated Net Income over 5 years is -$22.8 million, with a median of -$8.8 million recorded in 2023.
  • The sharpest move saw Consolidated Net Income tumbled 91059.26% in 2023, then surged 9661.88% in 2025.
  • Over 5 years, Consolidated Net Income stood at -$21.0 million in 2021, then surged by 131.31% to $6.6 million in 2022, then crashed by 243.64% to -$9.4 million in 2023, then dropped by 9.58% to -$10.3 million in 2024, then increased by 21.55% to -$8.1 million in 2025.
  • According to Business Quant data, Consolidated Net Income over the past three periods came in at -$8.1 million, -$11.0 million, and $19.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.